×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • VIVO CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $1.20 B
Last 13-F Filed: Q1 2026
Concentration in top 10: 59.33%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
SNSESensei Biotherapeutics Inc1.89%722,020$22,758,070722,020New$31.5213F
AVBPArrivent BioPharma Inc1.7%885,916$20,438,082885,916New$23.0713F
MANEVeradermics Inc1.57%300,000$18,945,000300,000New$63.1513F
ANTXAN2 Therapeutics Inc0.9%3,153,640$10,785,4493,153,640New$3.4213F
OKUROnkure Therapeutics Inc0.66%1,927,710$7,980,7191,927,710New$4.1413F
ALXOALX Oncology Holdings Inc0.53%3,184,713$6,385,3503,184,713New$2.0113F
MSLESatellos Bioscience Inc0.38%813,666$4,580,940813,666New$5.6313F
CMPSCompass Pathway PLC0.09%200,000$1,106,000200,000New$5.5313F